A comprehensive multicenter trial has quantified the incremental benefit of duraplasty in Chiari I surgery with striking precision: just 2.2 percentage points separate the two surgical approaches at 24-month follow-up. The landmark study, published in The New England Journal of Medicine, tracked 65.3% success rates for decompression with duraplasty versus 63.1% for decompression alone in patients with syringomyelia. This minimal difference challenges decades of surgical convention, suggesting that the addition of duraplasty may not justify the increased operative complexity and potential associated risks for many patients. Both groups demonstrated robust clinical outcomes exceeding 60% success, with comparable safety profiles showing serious complications in fewer than 5% of cases. The data indicates that surgeon expertise and patient-specific factors may carry greater weight in determining outcomes than the addition of this technically demanding procedure.
Was this article helpful?
